Zur Programmübersicht


How big pharma business model is a gamer changer for the PE market

28.02.2023 von 14:20 - 14:40

ICM Saal 13b

Sprache: Englisch

Vortragsart: Oral Presentation


GenesInk has changed its business model to speed up PE developments by proposing fine-tuned solutions and licensing contract which let to customer better TCO management.

This presentation will explain how this new business model is a game changer for the PE market by going through the following points :

  • GenesInk as an externalized R&D center
  • Partnership with technical centers
  • Inks licensing